lansoprazole has been researched along with Diseases of Pharynx in 8 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Globus pharyngeus and dysphagia are common complaints of patients referred to ear, nose, and throat (ENT) clinics." | 1.38 | Role of flexible transnasal esophagoscopy and patient education in the management of globus pharyngeus. ( Chen, CK; Chen, TM; Cheng, CC; Fang, TJ; Hsiao, HR; Huang, HC; Kuo, YL; Lee, LA; Lee, TJ; Li, HY; Lin, W; Yeh, AR, 2012) |
| "In the dysphagia group, 48 of 54 patients (89%) had edema of the posterior larynx, and 42 of 54 (78%) had laryngopharyngeal sensory deficits." | 1.31 | Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia. ( Aviv, JE; Close, LG; Kaplan, ST; Liu, H; Parides, M, 2000) |
| " Results were further analyzed to compare failure rates based on different dosage regimens." | 1.31 | Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux. ( Amin, MR; Digges, N; Johnson, P; Koufman, JA; Postma, GN, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DY | 2 |
| Jia, L | 2 |
| Gu, X | 1 |
| Jiang, SM | 2 |
| Xie, HL | 1 |
| Xu, J | 2 |
| Zhou, WC | 1 |
| Liu, Y | 1 |
| Liu, J | 1 |
| Yang, M | 1 |
| Dumper, J | 1 |
| Mechor, B | 1 |
| Chau, J | 1 |
| Allegretto, M | 1 |
| Cheng, CC | 1 |
| Fang, TJ | 1 |
| Lee, TJ | 1 |
| Lee, LA | 1 |
| Chen, TM | 1 |
| Chen, CK | 1 |
| Yeh, AR | 1 |
| Huang, HC | 1 |
| Hsiao, HR | 1 |
| Lin, W | 1 |
| Kuo, YL | 1 |
| Li, HY | 1 |
| Hill, RK | 1 |
| Simpson, CB | 1 |
| Velazquez, R | 1 |
| Larson, N | 1 |
| Aviv, JE | 1 |
| Liu, H | 1 |
| Parides, M | 1 |
| Kaplan, ST | 1 |
| Close, LG | 1 |
| Belafsky, PC | 1 |
| Postma, GN | 2 |
| Koufman, JA | 2 |
| Amin, MR | 1 |
| Johnson, P | 1 |
| Digges, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Placebo-Controlled Assessment of Lansoprazole 30 mg Bid in the Treatment of Gastroesophageal Reflux Associated With Laryngitis[NCT00369265] | Phase 4 | 18 participants (Actual) | Interventional | 2006-08-31 | Terminated (stopped due to Pharmaceutical company purchased by another company and funding was terminated.) | ||
| A Prospective Evaluation of the Utility, Optimal Cutoff and Positive Predictive Value of a Pharyngeal pH Probe for Predicting Proton Pump Inhibitor Response in Treatment Naive Laryngopharyngeal Reflux[NCT01755221] | 80 participants (Anticipated) | Interventional | 2012-08-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for lansoprazole and Diseases of Pharynx
| Article | Year |
|---|---|
Comparison of paroxetine and amitriptyline in the treatment of refractory globus pharyngeus.
Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety; China; Depression; Double-Blind Method; Female | 2016 |
The effects of paroxetine and amitriptyline on the upper esophageal sphincter (UES) pressure and its natural history in globus pharyngeus.
Topics: Adult; Amitriptyline; Antidepressive Agents; Esophageal Sphincter, Upper; Female; Humans; Lansoprazo | 2017 |
Lansoprazole in globus pharyngeus: double-blind, randomized, placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Ambulatory Care; Dose-Response Relationship, Drug; D | 2008 |
5 other studies available for lansoprazole and Diseases of Pharynx
| Article | Year |
|---|---|
Role of flexible transnasal esophagoscopy and patient education in the management of globus pharyngeus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Deglutition Disorders; Esophagoscopy; Female; | 2012 |
Pachydermia is not diagnostic of active laryngopharyngeal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2004 |
Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Deglutition Disorders; Fema | 2000 |
Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studie | 2001 |
Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studie | 2001 |
Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studie | 2001 |
Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studie | 2001 |
Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; | 2001 |